Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review, 71702 [2012-28784]
Download as PDF
71702
*
*
Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Rules and Regulations
*
*
§ 73.0
*
[FR Doc. 2012–29103 Filed 12–3–12; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
42 CFR Part 73
RIN 0920–AA34
Possession, Use, and Transfer of
Select Agents and Toxins; Biennial
Review
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Final rule; correction.
AGENCY:
The Department of Health and
Human Services is correcting a final
rule that appeared in the Federal
Register on October 5, 2012 (77 FR
61084). The document updated the list
of HHS and overlap biological agents
and toxins and designated certain select
agents and toxins as Tier 1 agents.
DATES: Effective Date: Effective
December 4, 2012.
FOR FURTHER INFORMATION CONTACT:
Robbin Weyant, Director, Division of
Select Agents and Toxins, Centers for
Disease Control and Prevention, 1600
Clifton Rd., MS A–46, Atlanta, GA
30333. Telephone: (404) 718–2000.
SUPPLEMENTARY INFORMATION: In FR Doc.
2012–24389, published on October 5,
2012 (77 FR 61084) appearing on pages
61086 and 61110, the following
corrections are made: Preamble
[Corrected]
1. On page 61086, in the second
column, second paragraph, beginning
on the fourth line, ‘‘According to
available reports, Lujo virus (1) caused
a fatal outbreak of hemorrhagic fever, (2)
has a case fatality rate of 80 percent, (3)
has been phylogenetically identified as
an arenavirus, and (4) is related to those
members of the Old World arenaviridae
family (Junin, Machupo, Sabia,
Guanarito, and Lassa) listed as HHS
select agents that cause hemorrhagic
fever and pose a significant risk to
public health and safety (Ref 2)’’ is
corrected to read: ‘‘According to
available reports, Lujo virus (1) caused
a fatal outbreak of hemorrhagic fever, (2)
has a case fatality rate of 80 percent, (3)
has been phylogenetically identified as
an arenavirus, and (4) is related to those
members of the Arenaviridae family
(Junin, Machupo, Sabia, Guanarito, and
Lassa) listed as HHS select agents that
cause hemorrhagic fever and pose a
significant risk to public health and
safety (Ref 2).’’
erowe on DSK2VPTVN1PROD with
SUMMARY:
VerDate Mar<15>2010
15:05 Dec 03, 2012
Jkt 229001
[Corrected]
2. On page, 61110, in the second
column, in § 73.0 (Applicability and
related requirements), in paragraph one,
‘‘All individuals and entities that
possess SARS-CoV, Lujo virus, or
Chapare virus must provide notice to
CDC regarding their possession of
SARS-CoV, Lujo virus, or Chapare virus
on or before November 5, 2012.
Currently registered individuals and
entities possessing SARS-CoV, Lujo
virus, or Chapare virus must meet all
the requirements of this part by
December 4, 2012. All previously
unregistered individuals and entities
possessing SARS-CoV, Lujo virus, or
Chapare virus must meet all of the
requirements of this part by April 3,
2013 is corrected to read: ‘‘All
individuals and entities that possess
SARS-CoV, Lujo virus, or Chapare virus
must provide notice to CDC regarding
their possession of SARS-CoV, Lujo
virus, or Chapare virus on or before
December 4, 2012. Currently registered
individuals and entities possessing
SARS-CoV, Lujo virus, or Chapare virus
must meet all the requirements of this
part by December 4, 2012. All
previously unregistered individuals and
entities possessing SARS-CoV, Lujo
virus, or Chapare virus must meet all of
the requirements of this part by April 3,
2013.’’
Dated: November 21, 2012.
Kathleen Sebelius,
Secretary.
[FR Doc. 2012–28784 Filed 12–3–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
44 CFR Part 67
[Docket ID FEMA–2012–0003]
Final Flood Elevation Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Final rule.
AGENCY:
Base (1% annual-chance)
Flood Elevations (BFEs) and modified
BFEs are made final for the
communities listed below. The BFEs
and modified BFEs are the basis for the
floodplain management measures that
each community is required either to
adopt or to show evidence of being
already in effect in order to qualify or
remain qualified for participation in the
SUMMARY:
PO 00000
Frm 00016
Fmt 4700
Sfmt 4700
National Flood Insurance Program
(NFIP).
DATES: The date of issuance of the Flood
Insurance Rate Map (FIRM) showing
BFEs and modified BFEs for each
community. This date may be obtained
by contacting the office where the maps
are available for inspection as indicated
in the table below.
ADDRESSES: The final BFEs for each
community are available for inspection
at the office of the Chief Executive
Officer of each community. The
respective addresses are listed in the
table below.
FOR FURTHER INFORMATION CONTACT: Luis
Rodriguez, Chief, Engineering
Management Branch, Federal Insurance
and Mitigation Administration, Federal
Emergency Management Agency, 500 C
Street SW., Washington, DC 20472,
(202) 646–4064, or (email)
Luis.Rodriguez3@fema.dhs.gov.
SUPPLEMENTARY INFORMATION: The
Federal Emergency Management Agency
(FEMA) makes the final determinations
listed below for the modified BFEs for
each community listed. These modified
elevations have been published in
newspapers of local circulation and
ninety (90) days have elapsed since that
publication. The Deputy Associate
Administrator for Mitigation has
resolved any appeals resulting from this
notification.
This final rule is issued in accordance
with section 110 of the Flood Disaster
Protection Act of 1973, 42 U.S.C. 4104,
and 44 CFR part 67. FEMA has
developed criteria for floodplain
management in floodprone areas in
accordance with 44 CFR part 60.
Interested lessees and owners of real
property are encouraged to review the
proof Flood Insurance Study and FIRM
available at the address cited below for
each community. The BFEs and
modified BFEs are made final in the
communities listed below. Elevations at
selected locations in each community
are shown.
National Environmental Policy Act.
This final rule is categorically excluded
from the requirements of 44 CFR part
10, Environmental Consideration. An
environmental impact assessment has
not been prepared.
Regulatory Flexibility Act. As flood
elevation determinations are not within
the scope of the Regulatory Flexibility
Act, 5 U.S.C. 601–612, a regulatory
flexibility analysis is not required.
Regulatory Classification. This final
rule is not a significant regulatory action
under the criteria of section 3(f) of
Executive Order 12866 of September 30,
1993, Regulatory Planning and Review,
58 FR 51735.
E:\FR\FM\04DER1.SGM
04DER1
Agencies
[Federal Register Volume 77, Number 233 (Tuesday, December 4, 2012)]
[Rules and Regulations]
[Page 71702]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-28784]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
42 CFR Part 73
RIN 0920-AA34
Possession, Use, and Transfer of Select Agents and Toxins;
Biennial Review
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services is correcting a
final rule that appeared in the Federal Register on October 5, 2012 (77
FR 61084). The document updated the list of HHS and overlap biological
agents and toxins and designated certain select agents and toxins as
Tier 1 agents.
DATES: Effective Date: Effective December 4, 2012.
FOR FURTHER INFORMATION CONTACT: Robbin Weyant, Director, Division of
Select Agents and Toxins, Centers for Disease Control and Prevention,
1600 Clifton Rd., MS A-46, Atlanta, GA 30333. Telephone: (404) 718-
2000.
SUPPLEMENTARY INFORMATION: In FR Doc. 2012-24389, published on October
5, 2012 (77 FR 61084) appearing on pages 61086 and 61110, the following
corrections are made: Preamble [Corrected]
1. On page 61086, in the second column, second paragraph, beginning
on the fourth line, ``According to available reports, Lujo virus (1)
caused a fatal outbreak of hemorrhagic fever, (2) has a case fatality
rate of 80 percent, (3) has been phylogenetically identified as an
arenavirus, and (4) is related to those members of the Old World
arenaviridae family (Junin, Machupo, Sabia, Guanarito, and Lassa)
listed as HHS select agents that cause hemorrhagic fever and pose a
significant risk to public health and safety (Ref 2)'' is corrected to
read: ``According to available reports, Lujo virus (1) caused a fatal
outbreak of hemorrhagic fever, (2) has a case fatality rate of 80
percent, (3) has been phylogenetically identified as an arenavirus, and
(4) is related to those members of the Arenaviridae family (Junin,
Machupo, Sabia, Guanarito, and Lassa) listed as HHS select agents that
cause hemorrhagic fever and pose a significant risk to public health
and safety (Ref 2).''
Sec. 73.0 [Corrected]
2. On page, 61110, in the second column, in Sec. 73.0
(Applicability and related requirements), in paragraph one, ``All
individuals and entities that possess SARS-CoV, Lujo virus, or Chapare
virus must provide notice to CDC regarding their possession of SARS-
CoV, Lujo virus, or Chapare virus on or before November 5, 2012.
Currently registered individuals and entities possessing SARS-CoV, Lujo
virus, or Chapare virus must meet all the requirements of this part by
December 4, 2012. All previously unregistered individuals and entities
possessing SARS-CoV, Lujo virus, or Chapare virus must meet all of the
requirements of this part by April 3, 2013 is corrected to read: ``All
individuals and entities that possess SARS-CoV, Lujo virus, or Chapare
virus must provide notice to CDC regarding their possession of SARS-
CoV, Lujo virus, or Chapare virus on or before December 4, 2012.
Currently registered individuals and entities possessing SARS-CoV, Lujo
virus, or Chapare virus must meet all the requirements of this part by
December 4, 2012. All previously unregistered individuals and entities
possessing SARS-CoV, Lujo virus, or Chapare virus must meet all of the
requirements of this part by April 3, 2013.''
Dated: November 21, 2012.
Kathleen Sebelius,
Secretary.
[FR Doc. 2012-28784 Filed 12-3-12; 8:45 am]
BILLING CODE 4163-18-P